An experimental pill might help people with stubborn high blood pressure that won’t relent to other treatments, clinical trial results show. Patients with treatment-resistant high blood pressure saw a significant drop after taking the new drug baxdrostat once a day for three months, researchers reported Aug. 30 in the New England Journal of Medicine. Blood pressure fell by 9 to 10 mm/Hg in those taking baxdrostat, results show. “This level of reduction is linked to substantially lower risk of heart attack, stroke, heart failure and kidney disease,” senior researcher Dr. Bryan Williams, chair of medicine at University College London, said in a news release. About 4 out of 10 baxdrostat patients achieved a healthy blood pressure, compared to fewer than 2 in 10 given a placebo tablet, researchers found. Baxdrostat works by blocking the body’s production of aldosterone, a hormone that helps the kidneys regulate salt and water balance. Some people produce too much aldosterone, causing their bodies to hold onto salt and water. This pushes blood pressure up and makes it hard to keep at a healthy level, researchers said. “Around half of people treated for hypertension do not have it controlled,” Williams said. “However, this is a conservative estimate and the number is likely higher, especially as the target blood pressure we try to reach is now much lower than it was previously.”… read on > read on >

















